Charles W. Popper

Learn More
Received Oct. 8, 2001; accepted Oct. 8, 2001. From the Department of Psychiatry, Harvard Medical School, Boston, and McLean Hospital, Belmont, Mass. Reprint requests to: Charles W. Popper, M.D., McLean Hospital, 115 Mill St., Belmont, MA 02478–1048 (e-mail: Charles_Popper@harvard.edu). N interfere with animal health, including aggressive and destructive(More)
Alternatives to psychostimulants are now a routine part of the pharmacologic treatment of ADHD. Bupropion and most tricyclic antidepressants are sound options for managing core behavioral symptoms and, to some extent, cognitive symptoms. Alpha 2 adrenergic agonists can moderately reduce hyperactivity and impulsivity. Certain effective agents, such as(More)
Complementary and alternative medicine (CAM) defies simple definition, because the distinction between CAM and conventional medicine is largely arbitrary and fluid. Despite inconclusive data on the efficacy and safety of many CAM treatments in child and adolescent psychiatry, there are enough data on certain treatments to provide guidance to clinicians and(More)
We administered the Measure of Aggression, Violence, and Rage in Children (MAVRIC; Bass, Geenens, & Popper, 1993a, 1993b), a questionnaire assessing the severity of reactive, impulsive aggression, to 28 prepubertal psychiatrically hospitalized children and 54 prepubertal lowrisk nonpatients and their mothers. Cross-informant reliability was supported(More)
Anxiety disorder is more prevalent than attention deficit disorder in children and adolescents, but its current drug treatment is based on inconclusive findings. Treatment of separation anxiety disorder without comorbidity has barely been studied. School absenteeism is often treated with tricyclic antidepressants and benzodiazepines, but the efficacy data(More)
A relatively unstressful technique for obtaining blood samples from rats has been employed to determine the amounts of catecholamines in blood during physiological sleep, undistrubed wakefulness, gentle handling and physical immobilization. These circulating plasma levels of catecholamines [0.46 ng of norepinephrine (NE) and 0.18 ng of epinephrine (EPI) per(More)
After the big scare ANC ongoing concern about the possibility that sudden death may be associated with antidepressant use in readolescent children, another problem with the pharmacologie treatment, of depression in adolescents is highlighted in this issue ofJCAP. A series of articles discuss the multiple research trials that have failed to demonstrate(More)
Empirical trials of psychotropic medications for treating behavioral and emotional disorders of adolescents and children are proceeding on a widespread basis. These trials are conducted in university settings and rural regions, and administered by specialists and generalists alike. For many of these treatments, there is only the most sketchy documentation(More)
IN every clinical encounter with every patient, clinicians make judgments about how to communicate information. Parents need facts about medications for their children. They cannot comfortably administer pills and support a child through medication treatment without sufficient information to be cognitively clear and affectively steady about their(More)